When generative AI meets the FDA: First digital health adcomm kicks off discussion

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Shareholders approve the sale of Evolva AG to Lallemand Inc. Swiss subsidiary at extraordinary general meeting – Biotech Investments

Evolva Holding SA / Key word(s): AGMEGMShareholders approve the sale of Evolva AG to Lallemand Inc. Swiss subsidiary at extraordinary general meeting21.12.2023 / 17:45 CET/CEST

December 22, 2023

Morning Rounds: Can you take GLP-1 drugs during pregnancy?

Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here. Buongiorno! We’re now officially in this

December 12, 2023

FDA Approves First Renal Denervation System for Hypertension

As expected, the FDA approved the Paradise ultrasound renal denervation system as an adjunctive treatment for hypertension, giving patients another option to control their blood

November 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.